Novartis pays $310 million upfront for inflammation specialist IFM

Deutschland Nachrichten Nachrichten

Novartis pays $310 million upfront for inflammation specialist IFM
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Novartis on Monday said it had agreed to pay $310 million (£238 million) upfront...

FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

ZURICH - Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline. The deal for the IFM subsidiary IFM Tre could eventually reach nearly $1.6 billion, IFM said in a statement, should the portfolio of clinical and preclinical molecules meet milestones. IFM has one molecule, IFM-2427, in an early Phase 1 trial, as well as other less-developed assets.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Duke to pay $112.5 million to settle allegation of falsifying research for federal grantsDuke to pay $112.5 million to settle allegation of falsifying research for federal grantsDuke University will pay the US government $112.5 million to settle allegations of falsifying research in order to obtain millions of dollars in federal grants, the Department of Justice announced
Weiterlesen »

U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialU.S. jury says Bayer must pay $81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court said the company was liable for
Weiterlesen »

Millions Are Being Lost To Apple Pay Fraud—Will Apple Card Come To The Rescue?Millions Are Being Lost To Apple Pay Fraud—Will Apple Card Come To The Rescue?Fraud perpetrated via Apple Pay might be the biggest yet, with other digital wallets abused too. Apple Card could prevent fraudsters loading up wallets with stolen credit card data.
Weiterlesen »

U.S. jury says Bayer must pay $80 million to man in Roundup cancer trialU.S. jury says Bayer must pay $80 million to man in Roundup cancer trialJury awards $80 million to man who claimed Bayer's Roundup weed killer caused his non-Hodgkin's lymphoma
Weiterlesen »

The 5 highest-paid CEOs of 2018, including $129 million for Discovery's David ZaslavThe 5 highest-paid CEOs of 2018, including $129 million for Discovery's David ZaslavThe highest-paid CEOs of 2018 include Discovery's David Zaslav and Disney's Bob Iger.
Weiterlesen »

GE Capital Pays $49 Million Over Petters Ponzi SchemeGE Capital Pays $49 Million Over Petters Ponzi SchemeGeneral Electric Capital Corp. reached the deal with a bankruptcy trustee who is digging up money for investors in two Florida hedge funds that lost $650 million when the Ponzi scheme collapsed in 2008, according to court papers entered Tuesday in the U.S. District Court in West Palm Beach, Fla.
Weiterlesen »

OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseOxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseThe case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
Weiterlesen »



Render Time: 2025-03-11 03:56:23